text_1: Diabetes drug may keep lung cancer at bay
text_2: Weaker on costs, quality of the evidence, benefits, harms, and comparison to other approaches or other research. That’s quite a few holes in comparison with the competition on this one. It’s interesting to learn that an inexpensive generic drug could have a positive effect against lung cancer. But this story didn’t deliver sufficient detail or context for readers to be able to judge the current state of the research.